Makes radiation detectors for nuclear plants and calibrates them in-house using a government licence competitors don't have.
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 4
- ScaleMarket cap is above the global median
Makes radiation detectors for nuclear plants and calibrates them in-house using a government licence competitors don't have.
What this company is and how it runs — written from structure, not news.
Mirion Technologies builds radiation detectors for nuclear power plants and DOE facilities, calibrating each one against radioactive sources it keeps on-site under an NRC materials licence before the instrument can legally enter a plant. Because most competitors lack that licence, they have to ship finished detectors to third-party calibration facilities, which makes it commercially impractical to tune each instrument to the customer-specific energy range the NRC requires — so once a plant installs a Mirion detector and gets it approved under plant-specific calibration procedures, switching to another manufacturer means restarting a regulatory approval process that takes months and requires rewiring safety systems. The same licence that blocks competitors from replicating this in one place is also the single point of failure: a security breach at the on-site source facility could trigger an NRC suspension that halts every certified shipment until the licence is reinstated. Even without that risk, the throughput ceiling sits with the clean room technicians who hand-align each crystal to its photomultiplier tube — that step cannot be automated, so the number of detectors the company can ship in any period is capped by qualified headcount, not by how many customers are asking.
How does this company make money?
The company earns money each time it sells a radiation detection instrument, ranging from handheld dosimeters to large fixed monitoring systems installed in nuclear facilities. It also collects recurring revenue by recalibrating those instruments every year — a service customers need to stay compliant with regulations. When detector components wear out and need replacing, the company sells those too. Because instruments last ten to fifteen years, a single sale generates a long tail of service and parts revenue over its lifetime.
What makes this company hard to replace?
Each installed radiation monitoring system is approved under NRC-mandated calibration procedures that are specific to that detector model. Swapping in a different manufacturer's instrument means going through a regulatory approval process that typically takes months. On top of that, the existing instruments are wired into plant safety systems, so replacing them requires extensive testing before the new equipment can be trusted. Customers are not simply choosing a preference — they are restarting a regulatory process.
What limits this company?
Every detector requires a technician to hand-align the crystal and the photomultiplier tube inside the clean room. That step cannot be done by a machine. So the number of detectors the company can ship in any given period is capped by how many trained technicians can work in that controlled space — not by how many orders come in or how much raw material is available.
What does this company depend on?
The company cannot operate without NIST-traceable radioactive calibration sources for certifying each instrument, high-purity germanium crystals from specialised semiconductor suppliers, cesium iodide and sodium iodide scintillation materials, and photomultiplier tubes from Hamamatsu or equivalent suppliers. It also depends on maintaining active NRC manufacturing licences for devices containing radioactive materials — without those, neither production nor calibration can legally proceed.
Who depends on this company?
Nuclear power plant operators rely on the company's detectors for the continuous area radiation monitoring that NRC regulations require — if those instruments stopped arriving, plants would lose a legally mandated safety capability. Medical facilities performing nuclear medicine procedures depend on its instruments to carry out required radiation safety surveys. DOE national laboratories use the detectors for materials characterisation work in weapons programs and research reactors, and would lose that capability if supply stopped.
How does this company scale?
The software that analyses radiation spectra and controls instruments can be copied to every new detector unit at essentially no extra cost — writing it once covers the whole product line. What does not scale easily is the physical work: every unit still needs a technician to hand-align the crystal and photomultiplier tube in the clean room, and every unit still needs individual calibration against the on-site radioactive sources. As the company grows, those two steps remain the ceiling.
What external forces can significantly affect this company?
If the NRC or DOE raises the sensitivity standards that detectors must meet, the company may have to redesign instruments at significant cost. International export controls on dual-use radiation detection technology can block sales to certain countries entirely. And when uranium prices swing, nuclear plant operators tend to cut or delay spending on monitoring equipment, which hits demand even if the company itself has done nothing wrong.
Where is this company structurally vulnerable?
If a security problem or a failed inspection at the on-site radioactive source facility caused the NRC to suspend the company's materials licence, the calibration step would immediately stop. No calibration means no certified detector. No certified detector means nothing can legally ship to a nuclear plant or DOE facility. The same licence that locks competitors out is the single point that, if lost, shuts down the entire production line until the NRC reinstates it.
Price is read as structure — trend, levels, range, peak and volatility drawn on the chart. It does not predict where price goes next.
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
4 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Three financing observations align: debt issuance is large relative to operating cash flow, absolute financing cash flow is large relative to operating cash flow, and long-term debt is a large share of total debt. Together they describe heavy financing activity with a long-term-debt-dominant mix.
How does this company use capital?
Four observations co-occur: free cash flow positive each of the last three fiscal years, revenue increased each of the last three fiscal years, trailing-statistics OCF margin elevated, and book value increased each of the last four fiscal years. The configuration describes multi-year fundamental persistence across cash flow, top line, margin, and equity accumulation.
Three observations align: revenue has increased every year over the trailing three years, receivables have increased every year over the trailing four years, and operating cash flow margin is on the industry-benchmarked scale. The picture is concurrent growth in revenue and receivables with peer-relative cash-conversion context.
How is this stock valued?
Three observations describe the present configuration: drawdown from the trailing peak is significant, free cash flow has been positive in each of the last three annual periods, and operating cash flow exceeded net income in the most recent annual period.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Companies that share the same coordination system — how they create, deliver, or capture value.
Companies that share active interpretations — structural patterns currently present in both stocks.
CompanyGraph